Showing 311-320 of 333 grants

Title Institution Researcher Program Duration Total Award Amount
Determining the role of new genes that may be involved in Type 1 Diabetes Pathogenesis Beth Israel Deaconess Medical Center Inc Ismail Syed Cures 01-June-2024 to 31-October-2025 $199,999.67
Defining and applying neo-epitope specific TCRs for engineered cell therapy Benaroya Research Institute at Virginia Mason Aïsha Callebaut Cures 01-March-2023 to 28-February-2026 $205,273.00
Assessing and mitigating T cell recognition of iPSC derived endocrine cells in Type 1 Diabetes Benaroya Research Institute at Virginia Mason Eddie James Cures 01-June-2024 to 31-May-2026 $500,000.00
Long-read approaches to identify coding, non-coding, and structural variation that contributes to T1D risk Benaroya Research Institute at Virginia Mason Eddie James Cures 01-September-2024 to 28-February-2026 $150,000.00
Cooperative harmonization and validation of an islet-specific AIM assay Benaroya Research Institute at Virginia Mason Karen Cerosaletti Cures 01-February-2024 to 31-January-2026 $299,998.00
Early immune and beta cell monitoring predicts treatment response Benaroya Research Institute at Virginia Mason S. Alice Long Cures 01-August-2019 to 31-July-2025 $2,499,814.79
GLUT1 Inhibition in type 1 diabetes Beckman Research Institute of the City of Hope Alberto Pugliese Cures 01-November-2022 to 31-July-2026 $494,072.25
Exploration of Age-Related Pancreatic Beta Cell Diversity in T1D Using Spatial Transcriptomics Beckman Research Institute of the City of Hope Farooq Syed Cures 01-October-2024 to 30-September-2025 $199,999.92
Modulation of beta cell mRNA Translation in Type 1 Diabetes Beckman Research Institute of the City of Hope Farooq Syed Cures 01-September-2024 to 31-March-2027 $444,138.25
Non-invasive immunoimaging of islet transplant rejection Beckman Research Institute of the City of Hope Fouad Kandeel Cures 01-June-2023 to 31-May-2026 $750,000.00